Introduction
============

Thyroid hormone is essential for somatic growth and neurodevelopment. Early infancy is a critical period in which adequate levels of thyroid hormone are required for normal brain development. Otherwise, irreversible neurological sequelae will ensue[@B1][@B2]. Therefore, early diagnosis and proper treatment for congenital hypothyroidism (CH) are important to prevent deleterious consequences such as mental retardation and growth failure[@B3].

As it is difficult to diagnose CH with clinical symptoms at birth, most patients with CH were diagnosed by laboratory results; low serum thyroid hormones and high serum thyroid-stimulating hormone (TSH) levels except for central hypothyroidism.

To avoid a delayed diagnosis, a neonatal screening test (NST) using capillary blood has been introduced in many countries. In Korea, a neonatal screening program for CH was initiated early in the 1990s[@B4]. Most centers in Korea evaluate TSH levels but some examine both TSH and free thyroxine (FT4) levels to screen for CH. If the TSH level is above the cutoff level at initial NST, a repeat NST or an evaluation of serum levels of TSH will be done. Thus, the initial neonatal TSH level is an important clue to decide on further evaluation and initiation of treatment.

TSH level is influenced by various factors[@B5][@B6][@B7][@B8]. However, some of the results are controversial and most of these studies investigated subjects including neonates with pathologic or abnormal conditions, such as preterm and sick babies. Prematurity itself, neonatal illness, and neonatal and maternal medications may influence neonatal TSH and thyroid hormone levels[@B5][@B6][@B7][@B9]

This study aimed to evaluate perinatal factors affecting neonatal TSH of healthy neonates born through normal vaginal delivery, excluding the effects of severe neonatal problems such as prematurity and pathologic conditions.

Materials and methods
=====================

1. Subjects
-----------

We performed a retrospective review of the medical records of 726 babies who were born through normal vaginal delivery at Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center, Seoul, Korea from January 2013 to December 2014 and discharged from the nursery. Of 726 newborns, 4 had a TSH level above 10 mIU/mL, which is the cutoff level for reevaluation. Follow-up TSH levels were at normal levels in 3 of them and they were included in this study. One of the 4 infants whose TSH levels were above 10 mIU/mL was diagnosed with CH. Two infants whose initial TSH levels were at normal levels had been taking thyroid hormone replacement under the suspicion of CH or transient TSH elevation. Seven infants whose sampling time was before 24 hours after birth and one baby whose sampling time was after 96 hours after birth were excluded. Ten neonates had congenital anomalies or perinatal problems (2 congenital heart disease, 3 renal anomaly, 1 syndactyly, 1 achondroplasia, 1 pineal cyst, 1 chromosomal anomaly, and 1 hypocalcemia). After excluding these 10 infants, 8 infants whose sampling time was early or late, and 3 others who were diagnosed with or suspected of having CH, 705 subjects were included in this study.

2. Methods
----------

Dried capillary blood spots were obtained by heel prick to measure TSH, FT4, and 17-α hydroxyprogesterone (17OHP) levels. Neonatal TSH levels were measured using an AutoDELFIA Neonatal hTSH kit (PerkinElmer, Waltham, MA, USA). Neonatal FT4 levels were measured using Microplate Neonatal FT4 (Bio-Rad, Hercules, CA, USA). An AutoDELFIA Neonatal 17a-OH-progesterone kit (PerkinElmer, Waltham, MA, USA) was used to measure neonatal 17OHP levels.

The normal levels of NST were as follows; TSH \<10.0 mIU/mL; FT4 \>0.7 ng/dL; 17OHP \<12.0 ng/mL.

Data on various factors were collected. Infant-related factors included sex, gestational age, birth weight, birth length, head circumference, sampling time, and Apgar scores (ASs). Delivery-related factors included mode of delivery, labor induction, and duration of the rupture of the membrane (ROM). Maternal factors included twin delivery, parity, maternal age, maternal disease, and maternal medication. Neonatal TSH levels were analyzed in relation to these perinatal factors and any associations with FT4 and 17 OHP levels.

3. Statistics
-------------

Statistical analyses were performed with IBM SPSS version 20.0 (IBM Co., Armonk, NY, USA). Variables were tested for a normal distribution. Levels of TSH, FT4, and 17OHP were log-transformed to normalize each distribution. Student *t*-test was used to compare TSH levels according to differences in perinatal factors. Pearson correlation analysis and stepwise linear regression analysis were applied to evaluate the relationship between TSH levels and continuous variables. A *P*-value of \<0.05 was considered statistically significant.

4. Ethics statement
-------------------

This study was approved by the Institutional Review Board of SMG-SNU Boramae Medical Center (IRB No. 16-2016-91/081). Informed consent was waived by the Board.

Results
=======

Clinical data and results of NSTs are shown in [Table 1](#T1){ref-type="table"}. TSH and 17OHP levels were examined in 705 newborns and FT4 was analyzed in 610 newborns. Of 705 neonates, 3 had an abnormal level of 17OHP (\>12.0 ng/mL) initially and a normal level subsequently. Of 610 newborns, no one had an abnormal FT4 level.

1. Infant factors
-----------------

Log transformed TSH level (lnTSH) was not related to gestational age, birth weight, birth length, or head circumference at birth ([Table 2](#T2){ref-type="table"}). There were no significant differences in TSH level according to the sex of the baby ([Table 3](#T3){ref-type="table"}). When subjects were divided into 2 groups by AS at 1 minute (\<7 vs. ≥7) and at 5 minutes (\<9 vs. ≥9), there were no differences in TSH level between the 2 groups ([Table 3](#T3){ref-type="table"}).

An inverse relationship was found between lnTSH and sampling time after birth (*r*=−0.100, *P*=0.008) ([Table 2](#T2){ref-type="table"}). There was a positive association between lnTSH and log transformed 17OHP level (ln17OHP) (*r*=0.22, *P* \<0.001) ([Table 2](#T2){ref-type="table"}) but not between lnTSH and log transformed FT4 level (lnFT4) ([Table 2](#T2){ref-type="table"}).

2. Delivery factors
-------------------

Infants born by vacuum-assisted delivery had higher lnTSH values than those born by spontaneous vaginal delivery (*P*=0.048) ([Table 3](#T3){ref-type="table"}). There were no significant differences in lnTSH according to labor induction ([Table 3](#T3){ref-type="table"}). Duration from ROM to birth was not associated with lnTSH ([Table 2](#T2){ref-type="table"}).

3. Maternal factors
-------------------

Maternal age was not related to lnTSH ([Table 2](#T2){ref-type="table"}). Twin newborns had higher values than singleton babies (*P*=0.026) ([Table 3](#T3){ref-type="table"}), and first babies had higher values than subsequent babies (*P*=0.011) ([Table 3](#T3){ref-type="table"}). There were no significant differences in TSH level according to the presence of maternal disease such as diabetes, hypertension, and thyroid disease. In addition, TSH level did not differ according to any medications being taken by mothers, such as insulin and L-thyroxine ([Table 3](#T3){ref-type="table"}).

4. Stepwise multiple linear regression
--------------------------------------

In stepwise multiple linear regression analyses including twin delivery, mode of delivery, birth order, sampling time, and ln17OHP as independent variables and lnTSH as the dependent variable, mode of delivery, birth order, sampling time, and ln17OHP were significant factors affecting lnTSH ([Table 4](#T4){ref-type="table"}).

Discussion
==========

This study showed that the TSH level of normal neonates born through vaginal delivery was influenced by mode of delivery and birth order. Vacuum-assistance delivery and first delivery were associated with higher neonatal TSH levels compared to spontaneous delivery and being a second or later child. TSH levels had a positive relationship with 17OHP levels and a negative relationship with sampling time, and were not related to neonatal FT4 levels.

Previous studies have reported that TSH levels in cord blood are higher in infants born through vaginal delivery than in those born through cesarean section[@B5][@B6][@B10][@B11][@B12][@B13], and higher in those born through vacuum-assisted delivery than in those born through spontaneous vaginal delivery[@B6][@B10][@B14]. Our results support these studies, although we investigated capillary blood TSH, not cord blood TSH, and infants born through cesarean section were excluded. In contrast, two studies have shown no difference in neonatal TSH level according to mode of delivery[@B8][@B15]. However, the subjects in one study included preterm and sick babies, and the authors did not consider vacuum-assisted delivery[@B15]. The other study also reported higher TSH levels in infants born with vacuum assistance compared to spontaneous vaginal delivery, although the difference was not significant[@B8]. Therefore, vacuum-assisted delivery itself or the condition prompting vacuum assistance is likely to increase neonatal TSH levels.

Many studies have reported that first babies have higher TSH levels than subsequent babies[@B6][@B7][@B12][@B14]. In contrast, one study from Belgium (where iodine insufficiency is common) reported no differences in TSH level according to birth order[@B8]. Herbstman et al.[@B6] assumed that this pattern might be related to environmental exposure, as some persistent chemicals are found at higher levels in firstborn children. In addition, the relatively more difficult labor associated with a first delivery compared to subsequent deliveries could increase TSH levels.

Glucocorticoid treatment may decrease serum levels of TSH through a direct inhibitory effect on thyrotropin releasing hormone (TRH); however, chronic high-dose glucocorticoids or cortisol excess in severe Cushing\'s syndrome do not have a significant effect[@B16]. 17OHP is a precursor of cortisol and its levels are higher in preterm and sick newborns[@B17]. When levels are high in term newborns without congenital adrenal hyperplasia, it may reflect some sort of stress. Therefore, a positive relationship between 17OHP and TSH may imply that stress during labor increases neonatal levels of TSH.

At birth, TSH levels surge in response to exposure to cold; they peak about 30 min after birth and then gradually decrease[@B18]. Generally, NSTs are performed 2 days after vaginal birth and 4 or 5 days after cesarean section in Korea. The sampling time of NST depends on the duration of hospital stay of mother and baby. Thus, we excluded neonates born through cesarean section, whose sampling times were much later than those of neonates born through vaginal delivery, from this study. As expected, the later the sampling time, the lower the level of TSH in babies born through normal vaginal delivery. This result is in accordance with previous studies on preterm infants and term infants[@B7][@B19].

Although the increased levels of FT4 after birth that we observed was due to increased levels of TRH and TSH, the lack of a correlation between TSH and FT4 implies an immature hypothalamic pituitary thyroid (HPT) axis in the early neonatal period.

Blunted TSH surges and delayed elevation of TSH levels are often observed in preterm babies who have an impaired hypothalamic pituitary responsiveness at birth[@B20]. Term babies also may have an immaturity of HPT axis in the early neonatal period. However, further studies about HPT axis in normal term babies will be required.

TSH level was not related to gestational age in this study. Many previous studies have reported that TSH levels increase with increasing gestational age[@B5][@B8][@B19][@B21][@B22]; however, an inverse relationship has also been reported[@B23], another study reported higher TSH levels in preterm than in term babies[@B6], and several other studies have reported no difference in TSH levels according to gestational age[@B10][@B13][@B15].

Although some studies have reported that low birth weight is related to high TSH levels[@B6][@B19][@B22][@B23], we did not find any association between birth weight and TSH level, in line with two previous reports[@B7][@B15]. Therefore, the relationship between TSH level and gestational age or birth weight seems to be different according to the study population.

Twin delivery is generally related to relative low birth weight, low gestational age, and increased maternal and fetal stress during labor. In our study, twin babies had higher TSH levels than singletons, but the difference was not significant in multivariate analyses, in line with previous works[@B7][@B22].

We did not find any significant differences in TSH level according to sex, in line with many previous studies[@B6][@B8][@B12][@B13][@B15][@B21][@B22]. However, a few studies have reported higher TSH levels in boys[@B7][@B14].

One study reported that neonates with asphyxia (AS at 1 minute\<3, and 5 minutes\<5) had higher TSH levels than neonates with 1 minute AS≥8 and 5 minutes AS≥9[@B9]. Another study reported high TSH levels with 1 minute AS\<6, but no difference in TSH level according to 5 minutes AS[@B5]. In contrast, Herbstman et al.[@B6] reported that infants with 5 minutes AS\<8 had higher TSH levels, but there were no differences in TSH level according to 1 minute AS. Some studies have reported no differences in TSH level according to AS[@B7][@B13][@B15], as we found. Subjects in this study were healthy normal babies with relatively high AS without birth asphyxia. Thus, they were a relatively homogeneous group in terms of AS. Besides, AS is related with an examiner\'s subjectivity.

Few studies have examined the relationship between TSH and labor induction. One study reported that preterm neonates born after labor induction had higher TSH levels[@B7]. Another study reported a relationship between TSH level and duration of labor[@B10]. However, we did not find a relationship between TSH level and labor induction. The reason for these different results is unknown. However, maternal and fetal stress levels might not be different between spontaneous and induced labor.

There was no relationship between TSH level and maternal age in our study, in line with most previous studies[@B6][@B7][@B8][@B12][@B13]. Only one study has reported a positive relationship between maternal age and TSH level[@B22].

The duration of ROM did not influence TSH level in this study. Few studies have examined this factor; one that did reported no relationship between TSH level and ROM, as we found[@B7].

Maternal disease such as overt and gestational diabetes, essential or pregnancy-induced hypertension, and hyper- or hypothyroidism did not affect TSH levels, in agreement with many previous studies[@B6][@B7][@B8][@B12][@B14] and in disagreement with one study in which the authors reported an increased TSH level in maternal diabetes and preeclampsia[@B5]. In addition, the use of medications to mothers did not affect TSH levels in our study. All of the infants in this study were born through a normal vaginal delivery. This means that any maternal diseases were well controlled with proper medications. These results suggest that a well-controlled maternal disease during pregnancy is not likely to influence neonatal TSH levels. Therefore, acute stress during labor may have caused the increases in TSH levels.

There were some limitations to this study. First, this is a cross-sectional retrospective study. Second, the NST was not as accurate as that of a serologic test for assessing TSH levels. Third, all of the factors possibly affecting TSH levels were not analyzed. For example, maternal and fetal levels of iodine were not evaluated. Iodine deficiency of mother and fetus could cause CH or an elevation of TSH level. Factors not included in this study may influence neonatal TSH levels.

Nonetheless, this study, conducted on normal babies without pathologic conditions, suggests that stress during labor may influence TSH levels even in normal newborns. In addition, this study is unique in that the relationship between neonatal TSH and 17OHP level was analyzed.

In conclusion, TSH levels of healthy, normal newborns are related to multiple factors. Acute stress during delivery may influence the neonatal TSH level in the early neonatal period. We should consider various perinatal conditions when evaluating neonatal TSH levels.
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###### Descriptive data on the subjects

![](apem-21-206-i001)

  Variable                  Mean±SD      Range
  ------------------------- ------------ --------------
  TSH (µIU/mL)              3.78±1.91    0.05--13.9
  FT4 (ng/dL)               2.36±0.94    0.7--5.4
  17OHP (ng/mL)             3.54±2.59    0.5--31.2
  Gestational age (wk)      38.86±1.22   35.0--42.9
  Birth weight (kg)         3.10±0.39    1.84--4.27
  Birth length (cm)         49.85±2.15   41.0--57.0
  Head circumference (cm)   33.77±1.24   30.0--38.0
  Maternal age (yr)         32.69±5.02   17.50--49.92
  Apgar score at 1 min      7.90±0.63    3--9
  Apgar score at 5 min      8.94±0.39    7--10
  Sampling time (hr)        44.69±8.95   24--95
  Duration of ROM (hr)      5.28±9.09    \<0.5--128

SD, standard deviation; TSH, thyroid stimulating hormone; FT4, free thyroxine; 17OHP, 17-α hydroxyprogesterone; ROM, rupture of membrane.

###### Pearson correlation analysis between TSH and perinatal factors
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  Variable             TSH       lnTSH               
  -------------------- --------- --------- --------- ---------
  Gestational age      --0.024   0.518     --0.001   0.972
  Birth weight         --0.062   0.101     --0.051   0.179
  Birth length         --0.054   0.152     --0.040   0.288
  Head circumference   --0.058   0.125     --0.037   0.323
  Sample time          --0.089   0.018     --0.100   0.008
  ROM                  0.017     0.651     0.022     0.555
  Maternal age         0.026     0.483     --0.003   0.945
  17OHP                0.164     \<0.001   0.170     \<0.001
  ln17OHP              0.208     \<0.001   0.220     \<0.001
  FT4                  0.020     0.611     0.027     0.487
  lnFT4                0.020     0.601     0.023     0.540

TSH, thyroid stimulating hormone; lnTSH, log transformed TSH; 17OHP, 17-α hydroxyprogesterone; ln17OHP, log transformed 17OHP; FT4, free thyroxine; lnFT4, log transformed free T4; ROM, rupture of membrane.

###### Comparison of TSH level according to perinatal factors
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  Variable                   No. (%)      TSH         *P*-value   lnTSH       *P*-value
  -------------------------- ------------ ----------- ----------- ----------- -----------
  Sex                                                                         
   Male                      373 (52.9)   3.85±1.90               1.22±0.52   
   Female                    332 (47.1)   3.69±1.92   0.257       1.17±0.53   0.200
  Multiple delivery                                                           
   Singleton                 679 (96.3)   3.75±1.89               1.19±0.52   
   Twin                      26 (3.7)     4.57±2.37   0.032       1.42±0.42   0.026
  Birth order                                                                 
   1st baby                  433 (61.4)   3.89±1.92               1.24±0.49   
   2nd or later baby         272 (38.6)   3.60±1.88   0.054       1.14±0.56   0.011
  Apgar score at 1 min                                                        
   \<7                       18 (2.6)     3.56±1.51               1.17±0.48   
   ≥7                        687 (97.4)   3.78±1.92   0.629       1.20±0.52   0.811
  Apgar score at 5 min                                                        
   7, 8                      65 (9.2)     4.12±1.93               1.30±0.50   
   9, 10                     640 (90.8)   3.74±1.91   0.126       1.19±0.52   0.099
  Delivery type                                                               
   Spontaneous               571 (81.0)   3.72±1.91               1.18±0.53   
   Vacuum assisted           134 (19.0)   4.01±1.91   0.111       1.28±0.49   0.048
  Labor type                                                                  
   Spontaneous               218 (30.9)   3.60±1.79               1.15±0.52   
   Induced                   487 (69.1)   3.85±1.96   0.104       1.22±0.52   0.115
  Maternal diabetes                                                           
   Normal                    653 (92.6)   3.75±1.89               1.19±0.52   
   GDM/DM                    52 (7.4)     4.14±2.10   0.149       1.29±0.53   0.191
  Maternal hypertension                                                       
   Normal                    688 (97.6)   3.77±1.92               1.20±0.52   
   PIH                       17 (2.4)     4.00±1.64   0.625       1.30±0.45   0.439
  Maternal thyroid disease                                                    
   Normal                    646 (91.6)   3.76±1.94               1.19±0.53   
   Hypothyroidism^a)^        52 (7.4)     3.98±1.70   0.439       1.28±0.47   0.245
   Hyperthyroidism^a)^       7 (1.0)      3.71±1.02   0.950       1.28±0.29   0.675
  Maternal medication                                                         
   None                      587 (83.3)   3.78±1.92               1.20±0.52   
   Insulin^b)^               22 (3.1)     3.79±2.23   0.969       1.16±0.62   0.693
   L-thyroxine^b)^           41 (5.8)     4.07±1.78   0.341       1.31±0.46   0.205
   Steroid^b)^               2 (0.0)      2.55±0.35   0.367       0.93±0.14   0.461

Values are presented as mean±standard deviation unless otherwise indicated.

TSH, thyroid stimulating hormone; lnTSH, log transformed TSH; GDM, gestational diabetes mellitus; DM, diabetes mellitus; PIH, pregnancy induced hypertension.

^a)^Maternal thyroid diseases in comparison with normal thyroid function. ^b)^Maternal medication in comparison with no medication.

###### Stepwise multiple linear regression analysis examining the influence of perinatal factors on variation in lnTSH
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  Variable              Coefficient   SE      *P*-value
  --------------------- ------------- ------- -----------
  (Constant)            1.252         0.103   \<0.001
  ln 17OHP              0.178         0.028   \<0.001
  1st baby^a)^          --0.106       0.040   0.008
  Sample time           --0.005       0.002   0.025
  Vacuum delivery^b)^   0.101         0.049   0.042

lnTSH, log transformed TSH; SE, standard error; ln17OHP, log transformed 17-α hydroxyprogesterone.

^a)^1st baby in comparison with 2nd or later baby. ^b)^Vacuum assisted delivery in comparison with normal spontaneous delivery.
